trial · primary record
MK-3120
Advanced Solid Tumors
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 270 |
| Primary completion | 2031-03-25 |
| Primary endpoint | Number of Participants Who Experience an Adverse Event (AE) |
| Registry ID | NCT06818643 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:20.174Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06818643
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.